Skip to content
Screener

Reported August 7, 2026 · Before market open

Revenue$1.5MMiss by $190.4K
EPS-$0.64Beat by $1.46
Revenue estimate$1.7M
EPS estimate-$2.10

Next report

Nov 18, 2026 (in 2 months)
Revenue estimate$1.9M
EPS estimate-$31.50

FAQ

When did bioAffinity Technologies, Inc. report Q2 2026 earnings?
bioAffinity Technologies, Inc. (BIAF) reported Q2 2026 earnings on August 7, 2026 before market open.
What were bioAffinity Technologies, Inc.'s Q2 2026 revenue and EPS?
bioAffinity Technologies, Inc. reported revenue of $1.5M and eps of $-0.64 for Q2 2026.
Did bioAffinity Technologies, Inc. beat estimates in Q2 2026?
Revenue missed the consensus estimate of $1.7M by $190.4K. EPS beat the consensus estimate of $-2.10 by $1.46.
How did bioAffinity Technologies, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 19.0% from $1.3M a year earlier and eps grew 83.6% from $-3.90.
Where can I find bioAffinity Technologies, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-036486) and the 10-Q periodic report (0001493152-26-036619) directly on SEC EDGAR. The filing index links above go to sec.gov.